Evidence mapPaperPMID 41509983Full record

ReviewMaterials today. Bio2026

Bioactive glass-based core-shell nanoparticles: Multifunctional platforms for controlled drug release and biomedical applications.

Arthur M Gabriel, Andrada-Ioana Damian-Buda, Fernanda M Brugnari, Emerson R Camargo, Aldo R Boccaccini

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arthur M GabrielInstitute of Biomaterials, University of Erlangen-Nuremberg, 91058, Erlangen, Germany.
Andrada-Ioana Damian-BudaInstitute of Biomaterials, University of Erlangen-Nuremberg, 91058, Erlangen, Germany.
Fernanda M BrugnariDepartment of Chemistry, Federal University of São Carlos, 13565-905, São Carlos, Brazil.
Emerson R CamargoDepartment of Chemistry, Federal University of São Carlos, 13565-905, São Carlos, Brazil.
Aldo R BoccacciniInstitute of Biomaterials, University of Erlangen-Nuremberg, 91058, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Core-shell engineered nanoparticles have emerged as multifunctional platforms for biomedical applications by enabling precise spatial control over their structure, controlled release, and interaction with biological tissues. Among the core materials, bioactive glasses offer unique advantages over conventional silica due to their intrinsic bioactivity and the release of therapeutic ions. This review provides a comprehensive analysis of core-shell nanostructures that use bioactive glass as the core, and shells composed of a wide range of inorganic and polymeric materials, engineered to control their release capabilities and biological performance. The composition and synthesis strategies of bioactive glass nanoparticles are discussed. The types of shell materials are also evaluated, highlighting their physicochemical roles in modulating drug diffusion, stability, degradation, and biological targeting. Inorganic, natural, and synthetic polymeric shells are discussed, focusing on how they can be used to tailor the properties of the nanoparticles. Key challenges related to in vivo performance assays, immunological responses, degradation behavior, and translational barriers, outlining future directions for clinical implementation, are also explored. By integrating the structural functionalities of bioactive glasses with advanced surface engineering, the core-shell structures discussed in this review represent a versatile, highly tunable and customizable strategy for next-generation biomedical therapies.

Indexed as

Bioactive glassBiomaterialsControlled drug releaseCore shell

Identifiers

PMID41509983
PMCPMC12774770

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.